Anzeige
Meldung des Tages: Portfoliowert bis 50 Mio. USD? Warum diese Gold-Microcap jetzt auffällt

Arcellx News

Aktie
WKN:  A3DEJC ISIN:  US03940C1009 US-Symbol:  ACLX Branche:  Biotechnologie Land:  USA
114,83 $
+0,03 $
+0,03%
97,937 € 10.04.26
Depot/Watchlist
Marktkapitalisierung *
3,08 Mrd. €
Streubesitz
-
KGV
-16,28
Index-Zuordnung
-

Arcellx News

19.03.26 - PR Newswire
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders? PR Newswire
18.03.26 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR PR Newswire
16.03.26 - PR Newswire
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders? PR Newswire
09.03.26 - PR Newswire
Are ACLX, DBRG, AVO, CVGW Obtaining Fair Deals for their Shareholders?
Are ACLX, DBRG, AVO, CVGW Obtaining Fair Deals for their Shareholders? PR Newswire
04.03.26 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--ACLX, VRE, EHAB, and CECO
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--ACLX, VRE, EHAB, and CECO PR Newswire
03.03.26 - PR Newswire
Are ACLX, VRE, LSF Obtaining Fair Deals for their Shareholders?
Are ACLX, VRE, LSF Obtaining Fair Deals for their Shareholders? PR Newswire
03.03.26 - PR Newswire
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion PR Newswire
23.02.26 - PR Newswire
Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders?
Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders? PR Newswire
23.02.26 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Arcellx, Inc. (NASDAQ: ACLX)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Arcellx, Inc. (NASDAQ: ACLX) PR Newswire
23.02.26 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire
23.02.26 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire
23.05.25 - PR Newswire
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
New Data and Deal Flow Signal a Turning Point for Precision-​Driven Cancer Biotechs PR Newswire
23.05.25 - PR Newswire
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
New Data and Deal Flow Signal a Turning Point for Precision-​Driven Cancer Biotechs PR Newswire

Newssuche

Videos

newspaper
07.04.26 -4,86%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »